Publications:

The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin.

Nature Cell Biology

Zhang, Yaohua Y; Li, Yajuan Y; Hu, Qingsong Q; Xi, Yutao Y; Xing, Zhen Z; Zhang, Zhao Z; Huang, Lisa L; Wu, Jianbo J; Liang, Ke K; Nguyen, Tina K TK; Egranov, Sergey D SD; Sun, Chengcao C; Zhao, Zilong Z; Hawke, David H DH; Li, Jin J; Sun, Deqiang D; Kim, Jean J JJ; Zhang, Ping P; Cheng, Jie J; Farida, Abid A; Hung, Mien-Chie MC; Han, Leng L; Darabi, Radbod R; Lin, Chunru C; Yang, Liuqing L

Publication Date: 2020-11

Variant appearance in text: DMD: F3228L

PubMed Link: 33106653

Variant Present in the following documents:

• NIHMS1630179-supplement-1630179_SourceDataFig2.xlsx, sheet 2
• nihms-1630179.pdf
• NIHMS1630179-supplement-1630179_ExtSourceDataFig2.xlsx, sheet 1

View BVdb publication page

Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports

Šimčíková, Daniela D; Heneberg, Petr P

Publication Date: 2019-12-09

Variant appearance in text: DMD: F3228L

PubMed Link: 31819097

Variant Present in the following documents:

• 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8

View BVdb publication page

X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy.

Pharmaceuticals (Basel, Switzerland)

Nakamura, Akinori A

Publication Date: 2015-06-09

Variant appearance in text: DMD: F3228L

PubMed Link: 26066469

Variant Present in the following documents:

• Main text
• pharmaceuticals-08-00303.pdf

View BVdb publication page